Anna Ida Fiaschi Selected Research

Drug Therapy (Chemotherapy)

1/2020	Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer.
12/2018	Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy.
9/2015	Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study.
9/2015	Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate.
4/2015	Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study.
4/2014	Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer.
3/2010	Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin.
1/2003	Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens.
10/2002	Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Ida Fiaschi Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 01/2008
6	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 12/2008
5	Disease Progression 01/2020 - 04/2015
4	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 03/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015 - 01/2003
2	Neutropenia 01/2020 - 04/2015
2	Cardiotoxicity 10/2017 - 01/2007
2	Stomach Neoplasms (Stomach Cancer) 08/2016 - 01/2008
2	Neoplasm Metastasis (Metastasis) 06/2011 - 12/2008
1	Adenocarcinoma 08/2020
1	Diarrhea 01/2020
1	Anemia 01/2020
1	Necrosis 01/2019
1	Inflammation (Inflammations) 01/2019
1	Varicocele 01/2019
1	Hand-Foot Syndrome 12/2018
1	Ovarian Epithelial Carcinoma 09/2015
1	Ovarian Neoplasms (Ovarian Cancer) 09/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015
1	Thrombocytopenia (Thrombopenia) 04/2015
1	Chronic Renal Insufficiency 12/2014
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2014
1	Bone Resorption 06/2011
1	Hyperthermia 08/2010
1	Breast Neoplasms (Breast Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 03/2010
5	Capecitabine (Xeloda)FDA Link 01/2020 - 01/2008
4	Abiraterone AcetateIBA 09/2015 - 04/2014
3	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2003
3	Bevacizumab (Avastin)FDA Link 12/2018 - 04/2015
3	Epirubicin (Ellence)FDA LinkGeneric 09/2015 - 12/2008
3	Fluorouracil (Carac)FDA LinkGeneric 09/2015 - 10/2002
2	Leucovorin (Folinic Acid)FDA Link 09/2015 - 10/2002
2	Gemcitabine FDA Link 04/2015 - 04/2015
1	CB2 Cannabinoid ReceptorIBA 08/2020
1	CannabinoidsIBA 08/2020
1	CannabidiolIBA 08/2020
1	Pharmaceutical PreparationsIBA 08/2020
1	Dronabinol (THC)FDA LinkGeneric 08/2020
1	CytokinesIBA 01/2019
1	CatalaseIBA 01/2019
1	Annexin A5IBA 01/2019
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2019
1	Propidium (Propidium Iodide)IBA 01/2019
1	ResistinIBA 01/2019
1	AdipokinesIBA 01/2019
1	regorafenibIBA 12/2018
1	Cocaine (Cocaine HCl)IBA 10/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2016
1	Biomarkers (Surrogate Marker)IBA 08/2016
1	apatinibIBA 08/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015
1	Carboplatin (JM8)FDA LinkGeneric 09/2015
1	Methotrexate (Mexate)FDA LinkGeneric 09/2015
1	taxaneIBA 09/2015
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 09/2015
1	cabazitaxel FDA Link 09/2015
1	Vinblastine (Vinblastine Sulfate)FDA Link 09/2015
1	Prednisone (Sone)FDA LinkGeneric 05/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2015
1	Cisplatin (Platino)FDA LinkGeneric 04/2015
1	Proteins (Proteins, Gene)FDA Link 10/2014
1	abirateroneIBA 04/2014
1	Zoledronic Acid (Zometa)FDA Link 06/2011
1	collagen type I trimeric cross-linked peptideIBA 06/2011
1	Alkaline PhosphataseIBA 06/2011
1	Ibandronic Acid (Boniva)FDA Link 06/2011
1	Collagen Type I (Type I Collagen)IBA 06/2011
1	Free RadicalsIBA 08/2010
1	Biological ProductsIBA 08/2010
1	Thymidine PhosphorylaseIBA 03/2010
1	Thymidylate SynthaseIBA 03/2010
1	Hormones (Hormone)IBA 12/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2008
1	CatecholaminesIBA 01/2007
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2007
1	Antineoplastic Agents (Antineoplastics)IBA 01/2003
1	AnthracyclinesIBA 10/2002
1	Taxoids (Taxanes)IBA 10/2002
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2002

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2020 - 10/2002
5	Therapeutics 01/2020 - 01/2015
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 09/2015
2	Maintenance Chemotherapy 01/2020 - 09/2015
2	Castration 09/2015 - 12/2014
1	Salvage Therapy 09/2015
1	Induction Chemotherapy 04/2015